Genmab — Februar 2024
-
Teller - very few insiders are Danish residents. They pay very different taxes to us....
-
None of them do
-
absolutely not - they just don't want to hold GEN stock
-
This is completely deja-vu from the old days - insiders sell like there is no tomorrow and shareholders are left with the pain
-
pain - no gain
-
Jeg erindrer ikke, at Genmab på noget tidspunkt har annuleret aktier i.f.m. et tilbagekøbsprogram. Som jeg husker det, er de tilbagekøbte aktier altid blevet anvendt til deres aflønningsprogrammer. Jeg kan huske fejl
-
-
Indtil nu er opkøb af egne aktier været under deres restricted stocks program. Mon ikke de 3,5 mia krs opkøb er til annulering af aktier eller “treasury shares” Der er i øvrigt en meget fyldestgørende beskrivelse af deres bonusprogram med årsrapporten. De mange restricted stocks senest er givet på baggrund af bl.a. Epcos godkendelse i 2023. For mig at se udløste det dobbelt bonus. Så de aktionærer der gider læse årsrapporten mv fra selskabet kan få det fulde overblik.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind